Complete report $11,500. DataPack (test volumes, sales forecasts, supplier shares) $7,500
2014 Strategies for the US Clinical Chemistry and Immunodiagnostic Market is a new strategic analysis of major business opportunities emerging in the US clinical chemistry and immunodiagnostic markets during the nextfive years. The report explores future trends in the US market; provides estimates of the specimen, test and sales volumes, as well as major suppliers sales and market shares; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities emerging during the next five years.
The report provides five-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in hospitals, commercial laboratories, physician offices, and ambulatory care centers, including controls, calibrators and consumables.
The clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments, like routine chemistry, are already resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace creates exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, and calibrators.
- New product development opportunities
with significant market appeal.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
- Strategic assessments of major suppliers and
emerging market entrants, including their sales, product
portfolios, marketing tactics, collaborative
arrangements and new products in R&D.
- The companies analyzed in the report include
Abbott, AdnaGen, Agilent, Alere, Beckman Coulter/Danaher,
Biomedical Diagnostics, bioMerieux, Bio-Rad, DiaSorin,
Eiken, Fujirebio/Innogenetics, IL, Kyowa Medex,
Ortho-Clinical Diagnotics, Roche, Siemens, Sysmex,
Thermo Fisher, Tosoh, Wako, Wallac/PE.
Tests Analyzed in the Report:
Routine Clinical Chemistry
Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, AST/SGOT, Bilirubin, Total,
BUN (Blood Urea Nitrogen), Calcium, Cardio CRP, Carbon Dioxide/Bicarbonate, Chloride,
Cholesterol, Creatine Kinase (CK), CK-MB, Creatinine, CRP, Ferritin, GGT, Glucose,
HDL Cholesterol, Homocysteine, Iron, LDH, LDL Cholesterol, Magnesium, Phosphorus,
Potassium, Protein, Total, Sodium, Triglycerides, Troponin, Uric Acid.
Therapeutic Drug Monitoring (TDM)
Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam,
Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus,
Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin.
Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH,
Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, TBG, Testosterone,
Thyroglobulin Ab, TPO Ab, TSH.
Tumor Markers and Special Chemistry
AFP, CA 15-3/27-29, CA 19-9, CEA, Ferritin, Follate (Folic Acid),
Glycosylated Hemoglobin, HCG, 25-Hydroxy Vitamin D2 and D3, Occult Blood,
PAP, PSA, Thyroglobulin, Vitamin B-12.
C3, C4, Free Light Chains, Haptoglobin, IgA, IgE Specific, IgE Total, IgG, IgM,
Immunofixation, Prealbumin, Protein Electrophoresis.
Drugs of Abuse
Amphetamines, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine,
LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP),
Propoxyphene, Tricyclic Antidepressants.
Market Segmentation Analysis
- Comprehensive review of the market
dynamics, trends, structure, size, growth,
and key suppliers.
- Test volume and sales forecasts for over 100 clinical chemistry,
TDM, endocrine, cancer, immunoprotein and abused drug assays,
by market segment:
Physician Offices/Group Practices
Current and Emerging Products
- Analysis of current and emerging clinical chemistry
and immunodiagnostic tests.
- Review of current instrumentation technologies, and feature comparison
of high-, medium-, and low-volume/POC analyzers.
- Assessment of current and emerging
technologies, and their potential market applications.
- Comprehensive lists of companies developing
or marketing new technologies and products by test.
Contains 600 pages and 120 tables
SIMILAR MARKET STUDIES
Notes: Sales, means the sales volume of Electric Pumps Revenue, means the sales value of Electric Pumps This report studies sales (consumption) of Electric Pumps in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for ...
February 2017 | $3900 | View Details >>
2014 Analysis of the Shigella Testing Market: US, Europe France, Germany, Italy, Spain, UK, Japan--Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Landscape
The report presents a detailed analysis of the Shigella diagnostics market in the US, Europe, France, Germany, Italy, Spain, UK and Japan. Current scientific views on the Shigella definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the ...
November 2013 | $2800 | View Details >>
Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950.SummaryThis comprehensive report contains 400 pages, 37 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the Spanish coagulation testing market during the next five years. The report explores business ...
September 2015 | $3950 | View Details >>
Complete report $6,800. DataPack (test volumes, sales forecasts, supplier shares) $3,950.VPGMarketResearch.com's new report is a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the German cancer diagnostics markets; reviews current and emerging tests; analyzes potential ...
September 2016 | $0 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research